Product Explainer

Enteric coated risedronate 35mg for the treatment of osteoporosis

Description

In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Andrew Sindone

Prof Andrew Sindone

Heart Failure – Demystifying Pharmacological Management for GPs

Dr Rupert Hinds

Dr Rupert Hinds

Iron Deficiency in Children & Young People

Speaker TBA

Speaker TBA

Heart Failure – Assessment and Monitoring in Primary Care

Prof Dave Singh

Prof Dave Singh

COPD Update

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Ego Seeman

expert

Prof Ego Seeman

Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis

Date published: 7 November 2023